Analysis of human antibodies to erythrocyte binding antigen 175 peptide 4 of Plasmodium falciparum

Clinical Medicine and Research

Volumn 4, Issue 1, 2006, Pages 1-6

  Touré, Fousseyni S ^a   Deloron, Philippe ^a,b   Migot Nabias, Florence ^c  

^a CENTRE INTERNATIONAL DE RECHERCHES MÉDICALES DE FRANCEVILLE   (Gabon)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^c Institut de Recherche pour le Developpement IRD   (Benin)

Author keywords

Clinical malaria; EBA 175 peptide 4; Immune response; Plasmodium falciparum

Indexed keywords

BINDING PROTEIN; ERYTHROCYTE BINDING ANTIGEN 175 PEPTIDE 4; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; UNCLASSIFIED DRUG;

ARTICLE; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; HUMAN; MALARIA; PLASMODIUM FALCIPARUM; RETROSPECTIVE STUDY;

ADOLESCENT; AGE FACTORS; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY FORMATION; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GABON; HUMANS; IMMUNOGLOBULIN G; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PROSPECTIVE STUDIES; PROTOZOAN PROTEINS; RETROSPECTIVE STUDIES;

EID: 33646083222     PISSN: 15394182     EISSN: None     Source Type: Journal    
DOI: 10.3121/cmr.4.1.1     Document Type: Article

References (41)

1. Camus D, Hadley TJ. A Plasmodium falciparum antigen that binds to host erythrocytes and merozoites. Science 1985;230:553-556.
2. Klotz FW, Orlandi PA, Reuter G, Cohen SJ, Haynes JD, Schauer R, Howard RJ, Palese P, Miller LH. Binding of Plasmodium falciparum 175-kilodalton erythrocyte binding antigen and invasion of murine erythrocytes requires N-acetylneuraminic acid but not its O-acetylated form. Mol Biochem Parasitol 1992;51:49-54.
3. Orlandi PA, Klotz FW, Haynes JD. A malaria invasion receptor, the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum recognizes the terminal Neu5Ac(alpha 2-3)Gal-sequences of glycophorin A. J Cell Biol 1992;116:901-909.
4. Sim BK, Chitnis CE, Wasniowska K, Hadley TJ, Miller LH. Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science 1994;264:1941-1944.
5. Kain KC, Lanar DE. Determination of genetic variation within Plasmodium falciparum by using enzymatically amplified DNA from filter paper disks impregnated with whole blood. J Clin Microbiol 199;29:1171-1174.
6. Sim BK. EBA-175: an erythrocyte-binding ligand of Plasmodium falciparum. Parasitol Today 1995;11:213-217.
7. Ware LA, Kain KC, Lee Sim BK, Haynes JD, Baird JK, Lanar DE. Two alleles of the 175-kilodalton Plasmodium falciparum erythrocyte binding antigen. Mol Biochem Parasitol 1993;60:105-109.
8. Sim BK. Sequence conservation of a functional domain of erythrocyte binding antigen 175 in Plasmodium falciparum. Mol Biochem Parasitol 1990;41:293-295.
9. Sim BK, Orlandi PA, Haynes JD, Klotz FW, Carter JM, Camus D, Zegans ME, Chulay JD. Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion. J Cell Biol 1990;111:1877-1884.
10. Daugherty JR, Murphy CI, Doros-Richert LA, Barbosa A, Kashala LO, Ballou WR, Snellings NJ, Ockenhouse CF, Lanar DE. Baculovirus-mediated expression of Plasmodium falciparum erythrocyte binding antigen 175 polypeptides and their recognition by human antibodies. Infect Immun 1997;65:3631-3637.
11. Okoyeh JN, Pillai CR, Chitnis CE. Plasmodium falciparum field isolates commonly use erythrocyte invasion pathways that are independent of sialic acid residues of glycophorin A. Infect Immun 1999;67:5784-5791.
12. Reed MB, Caruana SR, Batchelor AH, Thompson JK, Crabb BS, Cowman AF. Targeted disruption of an erythrocyte binding antigen in Plasmodium falciparum is associated with a switch toward a sialic acid-independent pathway of invasion. Proc Natl Acad Sci U S A 2000;97:7509-7514.
13. Narum DL, Haynes JD, Fuhrmann S, Moch K, Liang H, Hoffman SL, Sim BK. Antibodies against the Plasmodium falciparum receptor binding domain of EBA-175 block invasion pathways that do not involve sialic acids. Infect Immun 2000;68:1964-1966.
14. Grüner AC, Brahimi K, Letourneur F, Rénia L, Eling W, Snounou G, Druihle P. EBA-175 expression on malaria sporozoites. 12th British Society of Parasitology Malaria meeting. Leeds, UK, 2001.
15. Jones TR, Narum DL, Gozalo AS, Aguiar J, Fuhrmann SR, Liang H, Haynes JD, Moch JK, Lucas C, Luu T, Magill AJ, Hoffman SL, Sim BK. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen. J Infect Dis 2001;183:303-312.
16. Jakobsen PH, Heegaard PM, Koch C, Wasniowska K, Lemnge MM, Jensen JB, Sim BK. Identification of an erythrocyte binding peptide from the erythrocyte binding antigen, EBA-175, which blocks parasite multiplication and induces peptide-blocking antibodies. Infect Immun 1998;66:4203-4207.
17. Deloron P, Ringwald P, Luty AJ, Renaut A, Minh TN, Mbessy JR, Millet P. Relationships between malaria prevalence and malaria-related morbidity in school children from two villages in central Africa. Am J Trop Med Hyg 1999;61:99-102.
18. Migot-Nabias F, Luty AJ, Ringwald P, Vaillant M, Dubois B, Renaut A, Mayombo RJ, Minh TN, Fievet N, Mbessi JR, Millet P, Deloron P. Immune responses against Plasmodium falciparum asexual blood-stage antigens and disease susceptibility in Gabonese and Cameroonian children. Am J Trop Med Hyg 1999;61:488-494.
19. Rasheed FN, Bulmer JN, De Francisco A, Jawla MF, Jakobsen PH, Jepson A, Greenwood BM. Relationships between maternal malaria and malarial immune responses in mothers and neonates. Parasite Immunol 1995;17:1-10.
20. Migot-Nabias F, Deloron P, Ringwald P, Dubois B, Mayombo J, Minh TN, Fievet N, Millet P, Luty A. Immune response to Plasmodium falciparum liver stage antigen-1: geographical variations within central Africa and their relationship with protection from clinical malaria. Trans R Soc Trop Med Hyg 2000;94:557-562.
21. Druilhe P, Perignon JL. A hypothesis about the chronicity of malaria infection. Parasitol Today 1997;13:353-357.
22. Jensen JB, Hoffman SL, Boland MT, Akood MA, Laughlin LW, Kurniawan L, Marwoto HA. Comparison of immunity to malaria in Sudan and Indonesia: crisis-form versus merozoite-invasion inhibition. Proc Natl Acad Sci USA 1984;81:922-925.
23. Baird JK. Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol Today 1995;11:105-111.
24. Riley EM, Allen SJ, Wheeler JG, Blackman MJ, Bennett S, Takacs B, Schonfeld HJ, Holder AA, Greenwood BM. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol 1992;14:321-337.
25. Marsh K, Otoo L, Hayes RJ, Carson DC, Greenwood BM. Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans R Soc Trop Med Hyg 1989;83:293-303.
26. Bull PC, Lowe BS, Kortok M, Molyneux CS, Newbold CI, Marsh K. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat Med 1998;4:358-360.
27. Giha HA, Staalsoc T, Dodoo D, Roper C, Satti GM, Arnot DE, Hviid L, Theander TG. Antibodies to variable Plasmodium falciparum-infected erythrocyte surface antigens are associated with protection from novel malaria infections. Immunol Lett 2000;71:117-126.
28. Bouharoun-Tayoun H, Druilhe P. Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect Immun 1992;60:1473-1481.
29. Okenu DM, Riley EM, Bickle QD, Agomo PU, Barbosa A, Daugherty JR, Lanar DE, Conway DJ. Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum. Infect Immun 2000;68:5559-5566.
30. Da Silveira LA, Dorta ML, Kimura EA, Katzin AM, Kawamoto F, Tanabe K, Ferreira MU. Allelic diversity and antibody recognition of Plasmodium falciparum merozoite surface protein 1 during hypoendemic malaria transmission in the Brazilian amazon region. Infect Immun 1999;67:5906-5916.
31. Taylor RR, Smith DB, Robinson VJ, McBride JS, Riley EM. Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass. Infect Immun 1995;63:4382-4388.
32. Taylor RR, Allen SJ, Greenwood BM, Riley EM. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am J Trop Med Hyg 1998;58:406-413.
33. Jakobsen PH, Heegaard PM, Koch C, Wasniowska K, Lemnge MM, Jensen JB, Sim BK. Identification of an erythrocyte binding peptide from the erythrocyte binding antigen, EBA-175, which blocks parasite multiplication and induces peptide-blocking antibodies. Infect Immun 1998;66:4203-4207.
34. Bouharoun-Tayoun H, Attanath P, Sabchareon A, Chongsuphajaisiddhi T, Druilhe P. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med 1990;172:1633-1641.
35. Spiegelberg HL. Biological activities of immunoglobulins of different classes and subclasses. Adv Immunol 1974;19:259-294.
36. van de Winkel JG, Capel PJ. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 1993;14:215-221.
37. Burton DR, Gregory L, Jefferis R. Aspects of the molecular structure of IgG subclasses. Monogr Allergy 1986;19:7-35.
38. Auean C, Traore Y, Tall F, Nacro B, Traore-Leroux T, Fumoux F, Rihet P. High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria. Infect Immun 2000;68:1252-1258.
39. al-Yaman F, Genton B, Anders RF, Falk M, Triglia T, Lewis D, Hii J, Beck HP, Alpers MP. Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea. Am J Trop Med Hyg 1994;51:593-602.
40. al-Yaman F, Genton B, Anders R, Taraika J, Ginny M, Mellor S, Alpers MP. Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria. Parasite Immunol 1995;17:493-501.
41. Aribot G, Rogier C, Sarthou JL, Trape JF, Balde AT, Druilhe P, Roussilhon C. Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, west Africa). Am J Trop Med Hyg 1996;54:449-457.